The Supreme Court has restored broad access to the abortion pill mifepristone, blocking a ruling that had threatened to upend ...

The Louisiana lawsuit, which seeks to block telehealth prescribing and mailing of the abortion pill mifepristone, has major ...

The Supreme Court temporarily restored telehealth and mail access to the abortion pill mifepristone on Monday, responding to ...

Americans have a brand-new weight-loss option, and it’s a GLP-1 pill developed by Eli Lilly. The Food and Drug Administration on Wednesday approved Foundayo, an oral GLP-1 medication that is expected ...

The smart pill dispenser market offers growth opportunities driven by technological advancements, IoT connectivity, and ...

Introduction Medication non-adherence in older adults with long-term conditions contributes to significant morbidity, mortality and healthcare costs. While adherence support tools exist, many ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. INDIANAPOLIS, INDIANA - MARCH 17: A flag flies above the headquarters campus of Eli Lilly ...

Much to the relief of the needle-shy, the Food and Drug Administration has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January. But this new tablet, ...

The Food and Drug Administration on April 1 approved Eli Lilly's new weight-loss pill, giving consumers a second option in the growing non-injectable GLP-1 weight-loss drug market. Lilly said it will ...

Eli Lilly’s once-daily pill for weight loss got approval from U.S. drug regulators Wednesday. The all-clear sets up a battle with rival Novo Nordisk, which has been selling a pill version of its ...

Eli Lilly & Co.’s weight-loss pill won US approval, ratcheting up pressure on Novo Nordisk A/S, which launched an obesity pill earlier this year. Lilly’s once-daily pill, called Foundayo, was approved ...

Lilly pill led to 12%-15% reduction in body weight in clinical trials Will be sold as Foundayo and available beginning April 6 FDA fast-tracked approval under Trump-era voucher program The Lilly drug, ...